| scholarly article | Q13442814 |
| P356 | DOI | 10.3892/OL.2017.6817 |
| P8608 | Fatcat ID | release_lprfneq7tbbstn7uxkdfxj5p2m |
| P932 | PMC publication ID | 5649543 |
| P698 | PubMed publication ID | 29085445 |
| P50 | author | Tsunekazu Mizushima | Q79635797 |
| Taishi Hata | Q90245788 | ||
| Hirofumi Yamamoto | Q90288904 | ||
| Jun Koseki | Q92808632 | ||
| Masaki Mori | Q95423256 | ||
| Yuichiro Doki | Q95423257 | ||
| Hidekazu Takahashi | Q96291985 | ||
| Hideshi Ishii | Q114328213 | ||
| Naotsugu Haraguchi | Q114433215 | ||
| Nobuyoshi Ohara | Q114433354 | ||
| Yujiro Nishizawa | Q114563461 | ||
| Junichi Nishimura | Q39032671 | ||
| P2093 | author name string | Kenji Kawai | |
| P2860 | cites work | Scaffolding protein GOPC regulates tight junction structure. | Q40092371 |
| Interactions with PDZ domain proteins PIST/GOPC and PDZK1 regulate intracellular sorting of the somatostatin receptor subtype 5. | Q40398562 | ||
| The PDZ domain protein CAL interacts with mGluR5a and modulates receptor expression | Q48423163 | ||
| CFTR anion channel modulates expression of human transmembrane mucin MUC3 through the PDZ protein GOPC. | Q51765870 | ||
| The short-term outcomes of induction SOX (S-1 + oxaliplatin) ± cetuximab chemotherapy followed by short-course chemoradiotherapy in patients with poor-risk locally advanced rectal cancer. | Q53236494 | ||
| Pathogen recognition by the cell surface receptor CD46 induces autophagy | Q57275279 | ||
| Association of a novel PDZ domain-containing peripheral Golgi protein with the Q-SNARE (Q-soluble N-ethylmaleimide-sensitive fusion protein (NSF) attachment protein receptor) protein syntaxin 6 | Q24291274 | ||
| A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression | Q24291900 | ||
| A novel association of mGluR1a with the PDZ scaffold protein CAL modulates receptor activity | Q24316667 | ||
| A standard curve based method for relative real time PCR data processing | Q24811524 | ||
| Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer | Q27851407 | ||
| Cetuximab for the treatment of colorectal cancer. | Q27851419 | ||
| K-ras mutations and benefit from cetuximab in advanced colorectal cancer. | Q27851454 | ||
| Cancer statistics, 2015 | Q27860576 | ||
| Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer | Q27860681 | ||
| PIST: a novel PDZ/coiled-coil domain binding partner for the rho-family GTPase TC10 | Q28143319 | ||
| A kinase-regulated PDZ-domain interaction controls endocytic sorting of the beta2-adrenergic receptor | Q28145098 | ||
| Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21) | Q28186796 | ||
| Identification of a PDZ domain containing Golgi protein, GOPC, as an interaction partner of frizzled | Q28214292 | ||
| Interaction with cystic fibrosis transmembrane conductance regulator-associated ligand (CAL) inhibits beta1-adrenergic receptor surface expression | Q28281404 | ||
| Regulation of cystic fibrosis transmembrane regulator trafficking and protein expression by a Rho family small GTPase TC10 | Q28293683 | ||
| Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases | Q29614338 | ||
| MAP kinase signalling pathways in cancer | Q29615542 | ||
| Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial | Q29620127 | ||
| Syntaxin 6 and CAL mediate the degradation of the cystic fibrosis transmembrane conductance regulator | Q33761474 | ||
| Subcellular sorting of the G-protein coupled mouse somatostatin receptor 5 by a network of PDZ-domain containing proteins | Q35093658 | ||
| The golgi-associated PDZ domain protein PIST/GOPC stabilizes the β1-adrenergic receptor in intracellular compartments after internalization | Q35172907 | ||
| The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling | Q36061535 | ||
| The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions | Q36360691 | ||
| Dual-specificity MAP kinase phosphatases (MKPs) and cancer | Q37106291 | ||
| Mouse model of intrahepatic cholangiocarcinoma validates FIG-ROS as a potent fusion oncogene and therapeutic target | Q37353061 | ||
| Downregulation of ROS-FIG inhibits cell proliferation, colony‑formation, cell cycle progression, migration and invasion, while inducing apoptosis in intrahepatic cholangiocarcinoma cells | Q38980941 | ||
| Oxaliplatin and molecular-targeted drug therapies improved the overall survival in colorectal cancer patients with synchronous peritoneal carcinomatosis undergoing incomplete cytoreductive surgery | Q39140018 | ||
| P433 | issue | 4 | |
| P921 | main subject | colorectal cancer | Q188874 |
| P304 | page(s) | 4483-4490 | |
| P577 | publication date | 2017-08-24 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | Low expression of the GOPC is a poor prognostic marker in colorectal cancer | |
| P478 | volume | 14 |
Search more.